|
1
|
Villanueva A: Hepatocellular carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Collis MG and Hourani SM: Adenosine
receptor subtypes. Trends Pharmacol Sci. 14:360–366. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haskó G, Pacher P, Sylvester Vizi E and
Illes P: Adenosine receptor signaling in the brain immune system.
Trends Pharmacol Sci. 26:511–516. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haskó G, Linden J, Cronstein B and Pacher
P: Adenosine receptors: Therapeutic aspects for inflammatory and
immune diseases. Nat Rev Drug Discov. 7:759–770. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Blay J, White TD and Hoskin DW: The
extracellular fluid of solid carcinomas contains immunosuppressive
concentrations of adenosine. Cancer Res. 57:2602–2605.
1997.PubMed/NCBI
|
|
7
|
Cekic C, Sag D, Li Y, Theodorescu D,
Strieter RM and Linden J: Adenosine A2B receptor blockade slows
growth of bladder and breast tumors. J Immunol. 188:198–205. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Panjehpour M, Castro M and Klotz KN: Human
breast cancer cell line MDA-MB-231 expresses endogenous A2B
adenosine receptors mediating a Ca2+ signal. Br J Pharmacol.
145:211–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma DF, Kondo T, Nakazawa T, Niu DF,
Mochizuki K, Kawasaki T, Yamane T and Katoh R: Hypoxia-inducible
adenosine A2B receptor modulates proliferation of colon carcinoma
cells. Hum Pathol. 41:1550–1557. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vecchio EA, Tan CY, Gregory KJ,
Christopoulos A, White PJ and May LT: Ligand-independent adenosine
A2B receptor constitutive activity as a promoter of prostate cancer
cell proliferation. J Pharmacol Exp Ther. 357:36–44. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiang HJ, Liu ZC, Wang DS, Chen Y, Yang YL
and Dou KF: Adenosine A(2b) receptor is highly expressed in human
hepatocellular carcinoma. Hepatol Res. 36:56–60. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kolachala V, Asamoah V, Wang L, Obertone
TS, Ziegler TR, Merlin D and Sitaraman SV: TNF-alpha upregulates
adenosine 2b (A2b) receptor expression and signaling in intestinal
epithelial cells: A basis for A2bR overexpression in colitis. Cell
Mol Life Sci. 62:2647–2657. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xaus J, Mirabet M, Lloberas J, Soler C,
Lluis C, Franco R and Celada A: IFN-gamma up-regulates the A2B
adenosine receptor expression in macrophages: A mechanism of
macrophage deactivation. J Immunol. 162:3607–3614. 1999.PubMed/NCBI
|
|
14
|
Eltzschig HK, Ibla JC, Furuta GT, Leonard
MO, Jacobson KA, Enjyoji K, Robson SC and Colgan SP: Coordinated
adenine nucleotide phosphohydrolysis and nucleoside signaling in
posthypoxic endothelium: Role of ectonucleotidases and adenosine
A2B receptors. J Exp Med. 198:783–796. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kong T, Westerman KA, Faigle M, Eltzschig
HK and Colgan SP: HIF-dependent induction of adenosine A2B receptor
in hypoxia. FASEB J. 20:2242–2250. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stolze IP, Mole DR and Ratcliffe PJ:
Regulation of HIF: Prolyl hydroxylases. Novartis Found Symp.
272:15–36. 2006.PubMed/NCBI
|
|
17
|
Semenza GL: HIF-1: Upstream and downstream
of cancer metabolism. Curr Opin Genet Dev. 20:51–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eckle T, Kewley EM, Brodsky KS, Tak E,
Bonney S, Gobel M, Anderson D, Glover LE, Riegel AK, Colgan SP and
Eltzschig HK: Identification of hypoxia-inducible factor HIF-1A as
transcriptional regulator of the A2B adenosine receptor during
acute lung injury. J Immunol. 192:1249–1256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lan J, Lu H, Samanta D, Salman S, Lu Y and
Semenza GL: Hypoxia-inducible factor 1-dependent expression of
adenosine receptor 2B promotes breast cancer stem cell enrichment.
Proc Natl Acad Sci USA. 115:E9640–E9648. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
21
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C (T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tak E, Lee S, Lee J, Rashid MA, Kim YW,
Park JH, Park WS, Shokat KM, Ha J and Kim SS: Human carbonyl
reductase 1 upregulated by hypoxia renders resistance to apoptosis
in hepatocellular carcinoma cells. J Hepatol. 54:328–339. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eckle T, Brodsky K, Bonney M, Packard T,
Han J, Borchers CH, Mariani TJ, Kominsky DJ, Mittelbronn M and
Eltzschig HK: HIF1A reduces acute lung injury by optimizing
carbohydrate metabolism in the alveolar epithelium. PLoS Biol.
11:e10016652013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Selak MA, Armour SM, MacKenzie ED,
Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB
and Gottlieb E: Succinate links TCA cycle dysfunction to
oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer
Cell. 7:77–85. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tak E, Jun DY, Kim SH, Park GC, Lee J,
Hwang S, Song GW and Lee SG: Upregulation of P2Y2 nucleotide
receptor in human hepatocellular carcinoma cells. J Int Med Res.
44:1234–1247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dubey RK, Gillespie DG and Jackson EK:
A(2B) adenosine receptors stimulate growth of porcine and rat
arterial endothelial cells. Hypertension. 39:530–535. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grant MB, Tarnuzzer RW, Caballero S, Ozeck
MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC and
Belardinelli L: Adenosine receptor activation induces vascular
endothelial growth factor in human retinal endothelial cells. Circ
Res. 85:699–706. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mustafa SJ, Morrison RR, Teng B and Pelleg
A: Adenosine receptors and the heart: Role in regulation of
coronary blood flow and cardiac electrophysiology. Adenosine
Receptors in Health and Disease. Springer; pp. 161–188. 2009,
View Article : Google Scholar
|
|
30
|
Merighi S, Mirandola P, Varani K, Gessi S,
Leung E, Baraldi PG, Tabrizi MA and Borea PA: A glance at adenosine
receptors: Novel target for antitumor therapy. Pharmacol Ther.
100:31–48. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hockel M and Vaupel P: Tumor hypoxia:
Definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Volmer JB, Thompson LF and Blackburn MR:
Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue
protective in a model of bleomycin-induced lung injury. J Immunol.
176:4449–4458. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang M, Ma C, Liu S, Shao Q, Gao W, Song
B, Sun J, Xie Q, Zhang Y, Feng A, et al: HIF-dependent induction of
adenosine receptor A2b skews human dendritic cells to a
Th2-stimulating phenotype under hypoxia. Immunol Cell Biol.
88:165–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Eltzschig HK, Eckle T, Mager A, Küper N,
Karcher C, Weissmüller T, Boengler K, Schulz R, Robson SC and
Colgan SP: ATP release from activated neutrophils occurs via
connexin 43 and modulates adenosine-dependent endothelial cell
function. Circ Res. 99:1100–1108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feoktistov I and Biaggioni I:
Pharmacological characterization of adenosine A2B receptors:
Studies in human mast cells co-expressing A2A and A2B adenosine
receptor subtypes. Biochem Pharmacol. 55:627–633. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Igata M, Motoshima H, Tsuruzoe K, Kojima
K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D,
et al: Adenosine monophosphate-activated protein kinase suppresses
vascular smooth muscle cell proliferation through the inhibition of
cell cycle progression. Circ Res. 97:837–844. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao P, Li XG, Yang M, Shao Q, Wang D, Liu
S, Song H, Song B, Zhang Y and Qu X: Hypoxia suppresses the
production of MMP-9 by human monocyte-derived dendritic cells and
requires activation of adenosine receptor A2b via cAMP/PKA
signaling pathway. Mol Immunol. 45:2187–2195. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen H, Koupenova M, Yang D, Sume SS,
Trackman PC and Ravid K: Regulation of MMP-9 expression by the A2b
adenosine receptor and its dependency on TNF-α signaling. Exp
Hematol. 39:525–530. 2011. View Article : Google Scholar : PubMed/NCBI
|
